FI951514A0 - Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita - Google Patents

Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita

Info

Publication number
FI951514A0
FI951514A0 FI951514A FI951514A FI951514A0 FI 951514 A0 FI951514 A0 FI 951514A0 FI 951514 A FI951514 A FI 951514A FI 951514 A FI951514 A FI 951514A FI 951514 A0 FI951514 A0 FI 951514A0
Authority
FI
Finland
Prior art keywords
dna gyrase
gyrase inhibitors
new mono
bicyclic dna
bicyclic
Prior art date
Application number
FI951514A
Other languages
English (en)
Swedish (sv)
Other versions
FI951514A (fi
Inventor
Juergen Gelwiz
Erwin Goetschl
Paul Heibeisen
Helmut Link
Thomas Luebbers
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI951514A0 publication Critical patent/FI951514A0/fi
Publication of FI951514A publication Critical patent/FI951514A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/061,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D419/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
    • C07D419/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D419/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI951514A 1994-03-30 1995-03-30 Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita FI951514A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94104995 1994-03-30
EP95101595 1995-02-07

Publications (2)

Publication Number Publication Date
FI951514A0 true FI951514A0 (fi) 1995-03-30
FI951514A FI951514A (fi) 1995-10-01

Family

ID=26135552

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951514A FI951514A (fi) 1994-03-30 1995-03-30 Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita

Country Status (15)

Country Link
US (3) US5589473A (fi)
EP (1) EP0675122A3 (fi)
JP (1) JP2695132B2 (fi)
KR (1) KR950032185A (fi)
CN (2) CN1114648A (fi)
AU (1) AU694936B2 (fi)
CA (1) CA2144499A1 (fi)
CZ (1) CZ78895A3 (fi)
FI (1) FI951514A (fi)
HU (1) HUT72491A (fi)
IL (1) IL113123A (fi)
NO (1) NO304024B1 (fi)
NZ (1) NZ270801A (fi)
RU (1) RU95104899A (fi)
TW (1) TW343965B (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US5922883A (en) * 1996-04-03 1999-07-13 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
EP3632902B1 (en) 2003-04-11 2021-07-14 PTC Therapeutics, Inc. 1,2,4-oxadiazole benzoic acid compound and its use for nonsense suppression and the treatment of disease
GB0325830D0 (en) 2003-11-05 2003-12-10 Novartis Ag Organic compounds
FR2866887A1 (fr) * 2004-02-27 2005-09-02 Oreal Para-phenylenediamine secondaire n-heteroaryle, compositon tinctoriale comprenant une telle para-phenylenediamine, procede mettant en oeuvre cette composition et utilisation
US7329288B2 (en) 2004-02-27 2008-02-12 L'oreal S.A. N-heteroaryl secondary para-phenylenediamine, a dye composition comprising such a para-phenylenediamine, a process for preparing this composition and use thereof
GB0500683D0 (en) 2005-01-13 2005-02-23 Novartis Ag Organic compounds
CN101106994A (zh) * 2005-01-19 2008-01-16 默克公司 用于治疗阿尔茨海默氏病的氨基甲基β-分泌酶抑制剂
US7842810B2 (en) * 2005-03-31 2010-11-30 Janssen Pharmaceutica, Nv Bicyclic pyrazole compounds as antibacterial agents
MX2008012515A (es) 2006-03-30 2008-11-19 Ptc Therapeutics Inc Metodos para la produccion de proteina funcional a partir de adn que tiene una mutacion sin sentido y el tratamiento de trastornos asociados con la misma.
US7829709B1 (en) * 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
EP2252596B1 (en) * 2008-02-07 2016-12-28 Marquette University Cysteine and cystine prodrugs to treat schizophrenia and reduce drug cravings
EP2265594A2 (en) * 2008-04-16 2010-12-29 Marquette University Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
US8697704B2 (en) 2010-08-12 2014-04-15 Enanta Pharmaceuticals, Inc. Hepatitis C virus inhibitors
WO2012173410A2 (en) * 2011-06-14 2012-12-20 Green Cross Corporation Novel c-aryl ansa sglt2 inhibitors
WO2014181137A1 (en) 2013-05-10 2014-11-13 Karus Therapeutics Ltd Novel histone deacetylase inhibitors
KR102497273B1 (ko) 2014-03-06 2023-02-07 피티씨 테라퓨틱스, 인크. 1,2,4-옥사디아졸 벤조산의 약학 조성물 및 염
GB201419228D0 (en) * 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
BR112018008838A8 (pt) 2015-10-30 2019-02-26 Ptc Therapeutics Inc método para tratar, prevenir, melhorar ou administrar uma doença epiléptica

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE139532T1 (de) * 1991-04-17 1996-07-15 Hoffmann La Roche Neue dna-gyrase inhibitoren, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen

Also Published As

Publication number Publication date
IL113123A (en) 1999-11-30
IL113123A0 (en) 1995-06-29
CN1114648A (zh) 1996-01-10
EP0675122A3 (en) 1997-11-05
CA2144499A1 (en) 1995-10-01
KR950032185A (ko) 1995-12-20
HU9500860D0 (en) 1995-05-29
AU1507095A (en) 1995-10-12
US5594135A (en) 1997-01-14
JP2695132B2 (ja) 1997-12-24
AU694936B2 (en) 1998-08-06
NZ270801A (en) 1997-01-29
RU95104899A (ru) 1997-01-10
HUT72491A (en) 1996-05-28
TW343965B (en) 1998-11-01
FI951514A (fi) 1995-10-01
CN1308071A (zh) 2001-08-15
US5589473A (en) 1996-12-31
NO304024B1 (no) 1998-10-12
NO951210L (no) 1995-10-02
EP0675122A2 (en) 1995-10-04
NO951210D0 (no) 1995-03-29
CZ78895A3 (en) 1995-12-13
US5665746A (en) 1997-09-09
JPH07285953A (ja) 1995-10-31

Similar Documents

Publication Publication Date Title
FI951514A0 (fi) Uusia mono- ja bisyklisiä DNA-gyraasiinhibiittoreita
FI972970A0 (fi) Uusia yhdisteitä
DK0738150T3 (da) Bicykliske fibrinogene antagonister
FI20030162A (fi) Uusia yhdisteitä
DE59510926D1 (de) Bohrfutter
NO985222D0 (no) Karbolinderivater
DE19581725T1 (de) Spannfutter
DE69720531D1 (de) Laserinduzierte vergütete oberflächen
DE69528980D1 (de) Bohrfutter
FI954991A0 (fi) Bisyklisiä tetrahydropyrazolopyridiinejä
DE69514175T2 (de) Spannfutter
DE29521475U1 (de) Spannfutter
DE69807529T2 (de) Werkstück halteblock
DE59805075D1 (de) Zentriermaschine
DE69408656D1 (de) Plättchen-Halter
DE69515498D1 (de) Naphthyridinderivate
DE29719456U1 (de) Direktkablierspindel
FI974001A0 (fi) Nya metylenbisfosfonsyraderivat
NO970431D0 (no) Tetrahydroisokinolin-derivater
DE9401086U1 (de) Universalhalter
DE9405935U1 (de) Spannfutter
ZA952380B (en) Novel mono- and bicyclic DNA gyrase inhibitors
DE29510902U1 (de) Stromschienenhalterung
KR970060468U (ko) 미디어 시스템 교탁
DE29613928U1 (de) Zerlegbares Standbein